OncClubAll Oncology NewsPipeline Report
InsightsMedical World NewsOncChatsOncLive News Network®OncLive TVPeer ExchangePodcastsRapid ReadoutsThe Talk
Conference CoverageConference Listing
Giants of Cancer CarePER EventsScientific InterchangesState of the Science Summit / IPCWebinars
Partners
Oncology Live®Oncology FellowsSupplements And Featured PublicationsAll Publications
CME/CE
Interactive ToolsLearning ModulesPresentationsSponsored
Biomarker Consortium
Print SubscriptioneNewsletter
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
CAR T-cell Therapy
COVID-19
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-OncologyImmuno-OncologyImmuno-OncologyImmuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Business Management
Oncology Nursing News
Pediatric Oncology
Precision Medicine in Oncology®Precision Medicine in Oncology®
Sarcomas/TGCT
Supportive Care
Spotlight -
  • 2024 nominations are open for Giants of Cancer Care®
  • In-person and virtual events just for HCPs
  • REGISTER TODAY to explore data on a novel second-generation BTK inhibitor for adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).
  • Share your views with OncChats
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
CAR T-cell Therapy
COVID-19
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-OncologyImmuno-OncologyImmuno-OncologyImmuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Business Management
Oncology Nursing News
Pediatric Oncology
Precision Medicine in Oncology®Precision Medicine in Oncology®
Sarcomas/TGCT
Supportive Care
    • Partners
    • CME/CE
    • Biomarker Consortium
Advertisement

The Evolution of Chimeric Antigen Receptor T Cell Therapy

home / peer-exchange / evolution-car-t-therapy
Advertisement
Clinical Trial Data for Respective CAR T-Cell Therapies

EP. 1: Clinical Trial Data for Respective CAR T-Cell Therapies

January 8th 2019
A Historic Perspective on High-Risk Lymphoma Management

EP. 2: A Historic Perspective on High-Risk Lymphoma Management

January 8th 2019
CAR T-Cell Therapy: Real-World Applications

EP. 3: CAR T-Cell Therapy: Real-World Applications

January 8th 2019
Optimizing the Use of CAR T-Cell Therapy in Lymphoma

EP. 4: Optimizing the Use of CAR T-Cell Therapy in Lymphoma

January 8th 2019
Potential Use of CAR T-Cell Therapy Earlier in Sequencing

EP. 5: Potential Use of CAR T-Cell Therapy Earlier in Sequencing

January 8th 2019
Tisagenlecleucel for Pediatric and Young Adult ALL

EP. 6: Tisagenlecleucel for Pediatric and Young Adult ALL

January 8th 2019
Advertisement
Practical Applications of CAR T-Cell Therapy in ALL

EP. 7: Practical Applications of CAR T-Cell Therapy in ALL

January 8th 2019
Considering Differences Among CAR T-Cell Therapies

EP. 8: Considering Differences Among CAR T-Cell Therapies

January 8th 2019
CAR T-Cell Therapy's Role in the ALL Treatment Paradigm

EP. 9: CAR T-Cell Therapy's Role in the ALL Treatment Paradigm

January 8th 2019
CAR T-Cell Therapy in Adult Acute Lymphoblastic Leukemia

EP. 10: CAR T-Cell Therapy in Adult Acute Lymphoblastic Leukemia

January 8th 2019
CAR T-Cell Therapy: Understanding Indicators of Response

EP. 11: CAR T-Cell Therapy: Understanding Indicators of Response

January 8th 2019
Outpatient Administration Potential of CAR T-Cell Therapy

EP. 12: Outpatient Administration Potential of CAR T-Cell Therapy

January 8th 2019
Advertisement
Is the Community Setting Ready for CAR T-Cell Therapy?

EP. 13: Is the Community Setting Ready for CAR T-Cell Therapy?

January 8th 2019
CAR T-Cell Therapy in Other Disease Settings and Beyond

EP. 14: CAR T-Cell Therapy in Other Disease Settings and Beyond

January 8th 2019

Latest Conference Coverage

Dr Ganesan on the Use of ctDNA Assays For MRD Detection in Cancer Care

Dr Habib on Developments in Palliative Care For Patients With Cancer

Dr Boland on the Emergence of KRAS G12C Inhibitors in mCRC

Dr In on the Increased Incidence of Gastric Cancer in Minority Patient Populations

View More Latest Conference Coverage
Advertise
About OncLive
Editorial Board
CancerNetwork.com
CGTlive.com
CureToday.com
OncNursingNews.com
TargetedOnc.com
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777

© 2023 MJH Life Sciences

All rights reserved.
Home
About Us
News
Contact